Display options
Cite
Targum SD, Mischoulon D. The status of nutraceuticals for the treatment of depression. Psychiatry (Edgmont). 2009;6(9):46-8
Targum, S. D., & Mischoulon, D. (2009). The status of nutraceuticals for the treatment of depression. Psychiatry (Edgmont (Pa. : Township)), 6(9), 46-8.
Targum, Steven D, and Mischoulon, David. "The status of nutraceuticals for the treatment of depression." Psychiatry (Edgmont (Pa. : Township)) vol. 6,9 (2009): 46-8.
Targum SD, Mischoulon D. The status of nutraceuticals for the treatment of depression. Psychiatry (Edgmont). 2009 Sep;6(9):46-8. PMID: 19855861; PMCID: PMC2766289.
Copy Download .nbib Format: NLM
Share it on

Psychiatry (Edgmont). 2009 Sep;6(9):46-8.

The status of nutraceuticals for the treatment of depression.

Psychiatry (Edgmont (Pa. : Township))

Steven D Targum, David Mischoulon

Affiliations

  1. Dr. Targum is an executive-in-residence at Oxford BioScience Partners and on the faculty of the Department of Psychiatry at the Massachusetts General Hospital. Dr. Targum is chief medical officer at BrainCells Inc. and chief medical advisor to Prana Biotechnology Ltd. Dr. Targum is on the editorial board of Psychiatry 2009.

PMID: 19855861 PMCID: PMC2766289

[No abstract available.]

References

  1. J Clin Psychiatry. 2009 May;70(5):767; author reply 767-9 - PubMed
  2. J Clin Psychiatry. 2008 Sep;69(9):1352-3 - PubMed
  3. J Clin Psychiatry. 2006 Dec;67(12):1954-67 - PubMed
  4. Eur Neuropsychopharmacol. 2008 Sep;18(9):639-45 - PubMed
  5. J Clin Psychiatry. 2009 Dec;70(12):1636-44 - PubMed
  6. J Clin Psychiatry. 2008 Sep;69(9):1497-8 - PubMed
  7. J Clin Psychopharmacol. 2004 Dec;24(6):661-4 - PubMed
  8. Am J Clin Nutr. 2002 Nov;76(5):1158S-61S - PubMed

Publication Types